×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 ... [133]
内容类型
期刊论文 [100]
会议论文 [33]
发表日期
2019 [12]
2018 [30]
2017 [18]
2016 [17]
2015 [20]
2014 [15]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共133条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK-positive non-small cell lung cancer: A retrospective, real-world study
期刊论文
2019, 卷号: 8, 期号: 13, 页码: 5823-5830
作者:
Yang Guangjian
;
Ma Di
;
Xu Haiyan
;
Yang Lu
;
Li Junling
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
anaplastic lymphoma kinase inhibitor
crizotinib
crizotinib continuation beyond progressive disease
non-small cell lung cancer
treatment duration
REAL WORLD TREATMENT PATTERNS ANALYSIS FOR PATIENTS WITH ADVANCED OR METASTATIC LUNG CANCER IN THEIR INITIAL TREATMENT: A NATIONWIDE, MULTI-CENTER, RETROSPECTIVE MEDICAL CHART REVIEW IN CHINA (PASSION STUDY)
期刊论文
2019, 卷号: 22, 页码: S95-S95
作者:
Qiu, B.
;
Fan, L.
;
Tang, Z.
;
He, J.
;
Wang, P. F.
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
Apatinib as non -first -line treatment in patients with advanced cholangiocarcinoma
期刊论文
2019, 卷号: 30
作者:
Lin, J.
;
Yang, X.
;
Mao, J.
;
Wang, D.
;
Zhang, L.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 50
作者:
Liao Jun-Fang
;
Zhang Qun
;
Du Xiao-Jing
;
Lan Mei
;
Liu Shan
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2020/01/03
Apatinib as non -first -line treatment in patients with advanced cholangiocarcinoma
会议论文
ANNALS OF ONCOLOGY, 2019-07-01
作者:
Lin, J.
;
Yang, X.
;
Mao, J.
;
Wang, D.
;
Zhang, L.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 36
作者:
Zhou, Ming
;
Chen, Xiaoyuan
;
Zhang, Hong
;
Xia, Lin
;
Tong, Xin
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/01/03
Advanced non-small cell lung cancer
Anlotinib
Anti-angiogenesis
Epidermal growth factor receptor
Activating anaplastic lymphoma kinase
Adverse drug reaction
National Medical Products Administration
Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-small-cell lung cancer after crizotinib treatment
期刊论文
2019, 卷号: 31, 期号: 2, 页码: 349-356
作者:
Xu, Haiyan
;
Ma, Di
;
Yang, Guangjian
;
Li, Junling
;
Hao, Xuezhi
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
ALK
crizotinib
non-small-cell lung cancer
resistance
sequential therapy
Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib
期刊论文
2019, 卷号: 14, 期号: 3, 页码: 335-342
作者:
Mu, Yuxin
;
Hao, Xuezhi
;
Yang, Ke
;
Ma, Di
;
Wang, Shouzheng
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study
期刊论文
2019, 卷号: 17, 期号: 6, 页码: 4768-4778
作者:
Zhu, Anjie
;
Yuan, Peng
;
Wang, Jiayu
;
Fan, Ying
;
Luo, Yang
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
locally advanced or distantly metastatic breast cancer
pre-treatment
apatinib
chemotherapy
proteinuria
real-world clinical practice
Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
期刊论文
2019, 卷号: 132, 期号: 8, 页码: 922-927
作者:
Yang, Wen-Hui
;
Xie, Jun
;
Lai, Zhi-Yong
;
Yang, Mu-Dan
;
Zhang, Ge-Hong
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
Advanced non-small cell lung cancer
Chemotherapy
Combination therapy
Hyperthermia
©版权所有 ©2017 CSpace - Powered by
CSpace